26 Jul 2005 - Evotec AG and Almirall Prodesfarma S.A., the leading Spanish multinational company, announced that they have entered into a two-year library synthesis agreement.
Applying leading skills in high-speed parallel synthesis, medicinal and com-putational chemistry Evotec will design and synthesise for Almirall several thousand drug-like compounds across a wide range of chemical templates. With Evotec's state-of-the-art integrated autopurification and analytical plat-forms each compound will be of the highest purity to deliver high quality results in Almirall's pharmaceutical screening and medicinal chemistry pro-grammes.
 |
www.bionity.com/news/e/47879 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/47879 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |